We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

55 hedge funds and large institutions have $14.1M invested in Korro Bio in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $13M → $14.1M (+$1.1M)

0.05% less ownership

Funds ownership: 0.5% → 0.45% (-0.05%)

5% less funds holding

Funds holding: 58 → 55 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
16
Closed
9
Calls
$563K
Puts
–
Net Calls
+$563K
Net Calls Change
+$8K

Top Buyers

1
WA
Wasatch Advisors
Utah
+$176K
2
GCP
GSA Capital Partners
United Kingdom
+$76K
3
Jane Street
Jane Street
New York
+$49.9K
4
Charles Schwab
Charles Schwab
California
+$47.4K
5
Brown Advisory
Brown Advisory
Maryland
+$40.2K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$505K
2
Federated Hermes
Federated Hermes
Pennsylvania
-$462K
3
Citadel Advisors
Citadel Advisors
Florida
-$159K
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$157K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
EFS
26
Essex Financial Services
Connecticut
$36K – – –
Neuberger Berman Group
27
Neuberger Berman Group
New York
$36K – – –
Brown Advisory
28
Brown Advisory
Maryland
$35K +$40.2K +396 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$29K – – –
Bank of America
30
Bank of America
North Carolina
$27K -$4.47K -44 -13%
CSS
31
Cubist Systematic Strategies
Connecticut
$23K +$26.2K +258 New
CF
32
Centaurus Financial
California
$22K -$20.1K -198 -45%
Barclays
33
Barclays
United Kingdom
$21K -$3.65K -36 -13%
LP
34
LMR Partners
United Kingdom
$21K – – –
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$21K +$23.9K +235 New
CAM
36
Cubic Asset Management
Massachusetts
$20K – – –
TIM
37
Tortoise Investment Management
New York
$18K – – –
Verition Fund Management
38
Verition Fund Management
Connecticut
$18K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$16K +$2.94K +29 +19%
CG
40
Cutler Group
California
$12K – – –
UBS Group
41
UBS Group
Switzerland
$11K -$508 -5 -4%
JP Morgan Chase
42
JP Morgan Chase
New York
$4K +$1.42K +14 +54%
TWC
43
TD Waterhouse Canada
Ontario, Canada
$2.49K – – –
Osaic Holdings
44
Osaic Holdings
Arizona
$2K -$1.01K -10 -32%
CSB
45
City State Bank
Iowa
$2K – – –
Citigroup
46
Citigroup
New York
$1K -$2.03K -20 -71%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$1K -$1.52K -15 -56%
Carson Wealth (CWM LLC)
48
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Fidelity Investments
49
Fidelity Investments
Massachusetts
$1K – – –
Wells Fargo
50
Wells Fargo
California
$1K +$102 +1 +9%
1
2
3

KRRO Hedge Fund Activity: Q3 2022 in Review

55 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2022, worth a combined $14.1M — up 8.5% from $13M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of KRRO and 6 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Wasatch Advisors, adding an estimated $176K. The largest seller was Renaissance Technologies, cutting an estimated $505K.

  • 55 institutional investors held Korro Bio (KRRO) as of Q3 2022, down from 58 in Q2 2022.
  • Funds reported $14.1M of Korro Bio stock for Q3 2022, up 8.5% quarter-over-quarter.
  • 6 funds opened new Korro Bio positions in Q3 2022 and 9 closed out, a net change of -3 holders.
  • The largest Korro Bio buyer in Q3 2022 was Wasatch Advisors, an estimated $176K added.
  • The largest Korro Bio seller in Q3 2022 was Renaissance Technologies, an estimated $505K sold.

Based on aggregated 13F filings for Q3 2022.